Statistics
Publications
2
Citations
56
H-Index
2
Active since
2017
Affiliations
Johanna Ruemenapp is an author at University Hospital Schleswig-Holstein specializing in chronic myeloid leukemia therapy, molecular pharmacology, and oncology.
Publications per year
2017–2021
2
2
MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
Meike Kaehler, Johanna Ruemenapp, Daniel Gonnermann et al. · Oncotarget · 2017 · 32 citations · Full text
Medicine, Oncology, Pharmacology +15
1–2 of 2